Avanos Medical (AVNS) Research & Development (2013 - 2026)
Avanos Medical (AVNS) posted Research & Development of $5.2 million for Q1 2026, down 14.75% sequentially from $6.1 million in Q4 2025, and down 3.7% YoY from $5.4 million in Q1 2025.
Avanos Medical (AVNS) Research & Development (2013 - 2026) Analysis & Trends
Avanos Medical has reported Research & Development for 14 years, with the latest figure at $5.2 million in Q1 2026.
- Quarterly Research & Development fell 3.7% year-over-year to $5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.1 million (down 6.1% YoY) and the FY2025 annual result came in at $23.3 million, down 11.07% from the prior year.
- Research & Development retreated to $5.2 million in Q1 2026 per AVNS's latest filing, from $6.1 million in the prior quarter.
- Over five years, Research & Development peaked at $7.8 million in Q1 2022 and troughed at $5.2 million in Q1 2026.
- A 5-year average of $6.6 million and a median of $6.8 million in 2023 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2025: Research & Development climbed 22.03% in 2022, then declined 22.86% in 2025.
- Over 5 years, Research & Development stood at $7.2 million in 2022, then dropped by 5.56% to $6.8 million in 2023, then fell by 16.18% to $5.7 million in 2024, then rose by 7.02% to $6.1 million in 2025, then slipped by 14.75% to $5.2 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $5.2 million, $6.1 million, and $6.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 5.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.20 Mn |
| Dec 31, 2025 | 6.10 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 5.80 Mn |
| Mar 31, 2025 | 5.40 Mn |
| Dec 31, 2024 | 5.70 Mn |
| Sep 30, 2024 | 7.20 Mn |
| Jun 30, 2024 | 6.30 Mn |
| Mar 31, 2024 | 7.00 Mn |
| Dec 31, 2023 | 6.80 Mn |
| Sep 30, 2023 | 6.10 Mn |
| Jun 30, 2023 | 6.80 Mn |
| Mar 31, 2023 | 7.50 Mn |
| Dec 31, 2022 | 7.20 Mn |
| Sep 30, 2022 | 7.10 Mn |
| Jun 30, 2022 | 7.60 Mn |
| Mar 31, 2022 | 7.80 Mn |
| Dec 31, 2021 | 5.90 Mn |
| Sep 30, 2021 | 8.40 Mn |
| Jun 30, 2021 | 8.00 Mn |